Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$450,000.00
Oct 1, 2018
Novel individualized therapies in JAK/STAT driven T-cell malignancies
$449,500.00
Oct 1, 2018
Integrative Personal Omics Profiles in Glioblastoma Recurrence and Therapy Resistance
$100,000.00
Oct 1, 2014
MR-Guided Focal Laser Thermal Ablation of Prostate Cancer therapy
$105,000.00
Sep 1, 2015
Cognitive Behavioural Therapy for Fatigue in Chronic Hepatitis C Infection
$419,820.00
Jul 1, 2015
MR-Guided Focal Laser Thermal Ablation for Prostate Cancer therapy
$334,419.00
Jul 1, 2015
Image-guided device interventions for arterial therapies in liver cancer
$325,002.00
Apr 1, 2016
Improving care for cohesinopathies: from heart phenotypes to novel therapies
$416,060.00
Apr 1, 2016
Development of treatment planning platform for ultrasound stimulated microbubble therapy
$955,625.00
Jul 1, 2016
Developing novel GluN2A-containing NMDAR-based stroke therapies
$150,000.00
Dec 1, 2016
Guiding targeted therapies for brain metastases by identifying driver mutations